Overview

• On June 23, the NHS began prescribing Mounjaro to high-risk patients with obesity or related conditions at a standard prescription fee through GP surgeries in England.
• Jess Miles, 37, lost seven stone over nearly a year of private Mounjaro treatment and regained mobility, including flying without a belt extender and dropping to a UK size 18.
• Users report side effects from common symptoms like nausea and constipation to rare but serious risks such as pancreatitis and thyroid cancer, prompting the MHRA to keep safety data under review.
• Private patients who spent over £250 per month express frustration at recent NHS access but acknowledge the public system’s comprehensive health checks and monitoring.
• Miles plans to stop injections after her next dose and redirect her monthly spending toward gym workouts and swimming to maintain her weight loss.